Advanced Filters
noise
Found 65,447 clinical trials
B Bingjun Bai

Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer

This is a single-arm, prospective, multicenter study evaluating a novel neoadjuvant treatment strategy for patients with early, mid-low rectal adenocarcinoma that is microsatellite stable (MSS). Instead of irradiating regional lymph nodes, we deliver short-course radiotherapy (25 Gy in 5 fractions) exclusively to the primary tumor ("lymph-node-sparing" approach), immediately followed by …

18 - 80 years of age All Phase 2
B BeiJing Cancer Hospital EC

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

This is an open-label, multicenter Phase I/II clinical study conducted in participants with unresectable locally advanced or metastatic melanoma, aiming to evaluate the safety, tolerability, pharmacokinetic characteristics, and efficacy of JMT108 Injection in this population. The study consists of Phase I and Phase II (including Phase IIa and Phase IIb), …

18 years of age All Phase 1/2

A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment

The purpose of this study is to measure the pharmacokinetics (PK), safety, and tolerability of capivasertib in participants with moderate hepatic impairment and participants with normal hepatic function (as control).

18 - 80 years of age All Phase 1
E Elisa Canu, PhD

Neurocognitive Assessment Platform 4 Alzheimer

The aging population in Europe is leading to an increase in neurodegenerative diseases, such as Alzheimer's disease (AD), which is expected to affect 152 million people worldwide by 2050. In Italy, there are approximately 1.2 million cases of dementia, with 600,000 attributed to AD. Given the limited effectiveness of current …

55 - 80 years of age All Phase N/A
T Taisho Director Taisho Pharmaceutical Co., Ltd selected site

A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment

18 - 75 years of age All Phase 1
Z Zeycan Kahya, MD

Comparison of ESP and QL Blocks for Postoperative Pain in Pediatric Appendectomy (ESP-QLB)

This prospective randomized controlled clinical trial aims to compare the analgesic effectiveness of the Erector Spinae Plane (ESP) block and the Quadratus Lumborum (QL) block in pediatric patients undergoing appendectomy. Both regional anesthesia techniques have been shown to reduce opioid requirements and improve postoperative recovery in children; however, there is …

3 - 13 years of age All Phase N/A
K Katherine A Collins-Bennett, PhD

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they complete cardiac rehabilitation. Participants in this …

18 years of age All Phase N/A

Efficacy and Safety Study of 610 in Patients With Severe Asthma

The primary objective of the study is to evaluate the efficacy and safety of 610 in Chinese adults with severe asthma.

18 - 75 years of age All Phase 3
J Jasemin Todri, PhD

Validity - Reliability of Berg Balance Scale in Albanian Population

Cross-cultural adaptation, validity and Reliability of Berg Balance Scale in Albanian population

50 - 80 years of age All Phase N/A
K Kai-Hsiang Chen, M.D.

Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease

Spinal cord stimulation (SCS) has proven to be effective for pain that is unresponsive to medication. This technique involves an anesthesiologist or a neurosurgeon placing stimulation electrodes at the thoracic vertebrae to provide pain relief. Although SCS is not currently a standard treatment for patients with Parkinson's disease, recent studies …

40 - 85 years of age All Phase N/A

Simplify language using AI